DENTSPLY SIRONA Inc (NASDAQ:XRAY) Expected to Announce Earnings of $0.76 Per Share

Share on StockTwits

Analysts expect DENTSPLY SIRONA Inc (NASDAQ:XRAY) to announce $0.76 earnings per share for the current quarter, according to Zacks. Seven analysts have issued estimates for DENTSPLY SIRONA’s earnings, with the highest EPS estimate coming in at $0.78 and the lowest estimate coming in at $0.74. DENTSPLY SIRONA posted earnings of $0.58 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 31%. The company is scheduled to issue its next earnings report on Friday, March 6th.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full-year earnings of $2.44 per share for the current financial year, with EPS estimates ranging from $2.35 to $2.48. For the next fiscal year, analysts expect that the company will report earnings of $2.69 per share, with EPS estimates ranging from $2.60 to $2.82. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that cover DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.07. The business had revenue of $962.10 million for the quarter, compared to analyst estimates of $940.38 million. DENTSPLY SIRONA had a return on equity of 9.19% and a net margin of 2.67%. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.38 EPS.

XRAY has been the subject of several research analyst reports. Barclays increased their price objective on DENTSPLY SIRONA from $55.00 to $58.00 and gave the stock an “equal weight” rating in a report on Friday. Wellington Shields upgraded DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a report on Friday, August 2nd. Stifel Nicolaus increased their price objective on DENTSPLY SIRONA from $61.00 to $63.00 and gave the stock a “buy” rating in a report on Friday. ValuEngine cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Wednesday, October 2nd. Finally, Evercore ISI initiated coverage on DENTSPLY SIRONA in a report on Friday, July 26th. They issued an “in-line” rating for the company. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company. DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus price target of $57.37.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Altshuler Shaham Ltd raised its position in shares of DENTSPLY SIRONA by 209.8% in the 2nd quarter. Altshuler Shaham Ltd now owns 505 shares of the medical instruments supplier’s stock worth $30,000 after acquiring an additional 342 shares in the last quarter. Quest Capital Management Inc. ADV bought a new position in shares of DENTSPLY SIRONA in the 3rd quarter worth approximately $30,000. Rational Advisors LLC raised its position in shares of DENTSPLY SIRONA by 102.7% in the 3rd quarter. Rational Advisors LLC now owns 675 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 342 shares in the last quarter. Cornerstone Advisors Inc. raised its position in shares of DENTSPLY SIRONA by 62.0% in the 2nd quarter. Cornerstone Advisors Inc. now owns 904 shares of the medical instruments supplier’s stock worth $53,000 after acquiring an additional 346 shares in the last quarter. Finally, Van ECK Associates Corp bought a new position in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $54,000. Institutional investors and hedge funds own 93.46% of the company’s stock.

Shares of NASDAQ XRAY opened at $57.42 on Friday. The firm has a market capitalization of $12.31 billion, a P/E ratio of 28.57, a P/E/G ratio of 1.97 and a beta of 0.96. DENTSPLY SIRONA has a twelve month low of $34.93 and a twelve month high of $60.15. The stock’s 50-day simple moving average is $53.88 and its two-hundred day simple moving average is $54.19. The company has a quick ratio of 1.39, a current ratio of 2.08 and a debt-to-equity ratio of 0.30.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Further Reading: Determine Your Level of Risk Tolerance

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.